Bio-Techne Executive and Leadership Team

James Hippel, the Executive Vice President & Chief Financial Officer at Bio-Techne, manages all financial operations and strategic fiscal planning. Overseeing accounting, treasury, and investor relations, Hippel ensures Bio-Techne maintains strong financial health and supports its growth objectives. This critical role involves guiding capital allocation, managing financial risk, and providing insights that inform business strategy. By optimizing financial processes and driving fiscal discipline, James Hippel directly impacts Bio-Techne's capacity to invest in research, development, and market expansion. Ultimately, Hippel secures the financial resources and stability necessary for Bio-Techne to deliver innovative tools to the research and clinical diagnostic communities.

William Geist, the President, Protein Sciences Segment at Bio-Techne, leads the strategic direction and operational execution for the protein sciences division. Overseeing product development, market strategy, and commercial performance within this segment, Geist drives Bio-Techne's innovation in protein analysis tools. This executive role involves fostering advancements in reagents and assays that are crucial for biological investigations and disease research. By championing new product introductions and expanding market reach for protein-based solutions, William Geist directly enhances Bio-Techne's impact on the scientific community. Ultimately, Geist ensures the Protein Sciences Segment delivers high-quality, innovative tools that empower researchers and clinicians globally.

Cheryl Bethune, the Senior Vice President & Chief Human Resources Officer at Bio-Techne, directs all global human capital strategies. Overseeing talent acquisition, development, and retention, Bethune ensures Bio-Techne cultivates a high-performance culture aligned with its mission of advancing life sciences. This leadership role involves shaping employee engagement initiatives and fostering an environment that supports innovation and scientific rigor. By optimizing organizational structure and implementing robust HR policies, Cheryl Bethune directly contributes to Bio-Techne's ability to attract and retain top scientific talent. Ultimately, Bethune secures a skilled and motivated workforce essential for driving research and clinical diagnostic advancements.

Laurie Gilman, the Vice President, Finance Operations & Chief of Staff at Bio-Techne, oversees critical financial operations and provides strategic support to executive leadership. Managing day-to-day financial processes and acting as a key liaison across departments, Gilman ensures operational efficiency and alignment with Bio-Techne's strategic goals. This role involves streamlining financial workflows and facilitating effective communication between the finance function and other business units. By enhancing financial operational effectiveness and supporting executive decision-making, Laurie Gilman directly contributes to Bio-Techne's ability to execute its mission. Ultimately, Gilman ensures the smooth functioning of financial operations, supporting the company's commitment to providing innovative tools for scientific advancement.

Gary Latham, the Vice President - Chief Technology Officer at Bio-Techne, directs the company's technological vision and infrastructure development. Overseeing all aspects of information technology and digital strategy, Latham ensures Bio-Techne leverages cutting-edge technology to support its research and diagnostic tools. This leadership position involves driving innovation in data management, cybersecurity, and platform development to enhance product offerings and operational efficiency. By architecting scalable technology solutions and fostering a culture of digital transformation, Gary Latham directly advances Bio-Techne's capabilities. Ultimately, Latham ensures the technological foundation is robust, enabling the company to provide advanced tools for scientific investigation and clinical diagnostics.